Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner and 1 distinct art unit. All current activity is centered on this technical dispute. This profile involves an allocation of resources toward resolving the outstanding issues in this case. The prosecution is limited to the 1 art unit and the 1 examiner identified in the data.
The busiest examiner for the company is TAYLOR, LIA ELAN, who is responsible for 1 pending office action. This figure represents the company's current pending workload. Because there is 1 examiner and 1 art unit involved, practitioners can focus their strategy on the specific requirements and past behaviors of this individual. The activity occurs within the Biotechnology & Pharmaceuticals sector and requires addressing the specific standards of TAYLOR, LIA ELAN. The outcome of the portfolio is currently dependent on the results of this 1 pending office action.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RYAN, DOUGLAS CHARLES | 1 | 39.2% | +47.6% |
| TAYLOR, LIA ELAN | 1 | 64.4% | +29.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18042193 | A METHOD FOR THE ISOLATION OF DOUBLE-STRAND BREAKS | RYAN, DOUGLAS CHARLES | 3d overdue |
| 17636425 | Anti-C7 Antibody Or Antibody Fragment | TAYLOR, LIA ELAN | 19d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18042193 | A METHOD FOR THE ISOLATION OF DOUBLE-STRAND BREAKS | RYAN, DOUGLAS CHARLES | 3d overdue |
| 17636425 | Anti-C7 Antibody Or Antibody Fragment | TAYLOR, LIA ELAN | 19d |
| Art Unit | Apps |
|---|---|
| 1635 | 1 |
| 1641 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18042193 | A METHOD FOR THE ISOLATION OF DOUBLE-STRAND BREAKS | RYAN, DOUGLAS CHARLES | 1635 | §101§102§103§112Other | Final Rejection | 3d overdue | Pending | Feb 17, 2023 |
| 17636425 | Anti-C7 Antibody Or Antibody Fragment | TAYLOR, LIA ELAN | 1641 | §101§112 | Final Rejection | 19d | Pending | Feb 18, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial